Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced MedTech, formerly known as Accuron MedTech Group, is the largest medical technology group in Southeast Asia and a global leader in urological solutions. Headquartered in Singapore and wholly owned by Temasek, the company specializes in the development and commercialization of innovative medical devices and digital health technologies. Its core portfolio includes Dornier MedTech, the inventor of the first lithotripter, which provides advanced shock wave lithotripsy and surgical laser systems for treating kidney stones and prostate conditions. Beyond urology, the group actively invests in and incubates high-growth healthcare ventures in areas such as renal care and robotic surgery. Advanced MedTech maintains a global footprint with operations in over 100 countries, focusing on improving patient outcomes through integrated healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accuron MedTech Group.